Trial Profile
Oral glucocorticoids-sparing effects of tocilizumab and other biologic Dmards in patients with rheumatoid arthritis patients: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 01 Feb 2016 New trial record